FinCanna: Cannabis Extraction Across Northern & Southern California
Ryan Allway
April 18th, 2018
Exclusive, News, Top News
California’s cannabis industry is projected to reach $7.7 billion in revenue by 2021, according to BDS Analytics and Arcview Group, driven by the legalization of adult-use cannabis this year. While Northern California has historically been the most receptive to cannabis legalization, Southern California has evolved its stance and accelerated the market’s growth. Investors may want to look for companies with exposure to both parts of the market.
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company focused on the licensed medical sector that has agreements for a planned six acre medical cannabis campus and two medical cannabis extraction facilities located in Northern and Southern California, one of which is already in operation. Investors may want to take a closer look at the stock given FinCanna’s near-term and long-term revenue potential.
California’s Burgeoning Market
California unveiled its largest cannabis reform since 1996 with the passage of Proposition 64 in 2016. The new law allows adults aged 21 years or older to possess and use marijuana for recreational purposes, while requiring businesses to obtain state and/or local licenses to sell the drug. The state also introduced two new excise taxes, including a cultivation and retail tax, in order to raise money for drug treatment and other programs.
According to BDS Analytics and Arcview Group, California’s marijuana industry could generate more than $7.7 billion in legal sales by 2021, which will make it one of the largest legal markets in the world. The Bright Field Group estimates that cannabis concentrates continue to be one of the fastest growing categories following recreational legalization. These trends open the door for companies involved with large-scale cannabis extraction operations.
Despite its rapid growth potential, California could see some issues with adequate supply down the road. The new rules have changed the game for many existing growers that have been forced to either shut down or relocate to licensed facilities. In fact, of the state’s estimated 68,150 cannabis cultivators, only 534 are actually licensed to cultivate cannabis, according to Green Market Report, which opens the door for cannabis campus operations.
FinCanna’s Two Extraction Facilities
FinCanna’s initial investment is in Cultivation Technologies Inc. (“CTI”), which is planning to develop a medical cannabis campus on its six acre site in Coachella. While this project is being developed, CTI established an interim medical cannabis extraction facility in accordance with its Conditional Use Permit. The facility is capable of processing up to 6,000 pounds of biomass per month, which translates to about 3.7 million grams of raw oil per year – with ample room for expansion.
Under the terms of its agreement, FinCanna is entitled to receive 50 percent of the profits from this facility, which had been operated by a third-party tenant of CTI. Since taking operational control of the Extraction Facility, CTI has acquired key accounts for contracted manufacturing and distribution. Private label services have also commenced on the site, providing brands which otherwise had no legal avenue to participate in the licensed environment, a legal solution to maintain their presence in the market.
On February 15, FinCanna signed a binding term sheet with Gram Co Holdings LLC with regards to its Oakland-based cannabinoid research and refinement facility. Under the terms of the deal, FinCanna will invest $3 million in tranches in exchange for a tiered corporate royalty, ranging from 7.5 percent to 14 percent of Gram Co’s revenue. The move provides investors with access to the lucrative Northern California market.
Gram Co’s leased facility is being retrofitted to become a large, state-of-the-art medical cannabis extraction laboratory that’s expected to be operational by the end of the third quarter. Using its hydrocarbon-based solvent extraction methods, the company aims to become a premier producer of bulk concentrates. Gram Co also plans to provide white labeling services to licensed brands and infused product manufacturers that don’t have direct market access.
Looking Ahead
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) represents a compelling investment opportunity in California’s burgeoning market. With an extraction facility operating in Southern California, an extraction facility expected in Northern California as well as its royalty interest in a state-of-the-art software compliance solution company for the licensed medical cannabis sector, FinCanna has diversified exposure to the market. CTI’s planned six acre campus in Coachella also opens the door to a much larger scale and long-term play on the rapidly growing cannabis industry.
For more information and to read the company’s statement regarding potential risks visit www.fincannacapital.com
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please see our disclaimer below and follow the link to view our full disclosure outlining compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Pivot Pharmaceuticals Inc. is an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals.
Resolve Digital Health Inc. committed to establishing a standard of care missing from the medical cannabis industry until now.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
